Renal biopsy for diagnosis in kidney disease

• Verfasst von: Schnülle, Peter [VerfasserIn]
• Titel: Renal biopsy for diagnosis in kidney disease
• Titelzusatz: indication, technique, and safety
• Verf.angabe: Peter Schnuelle
• E-Jahr: 2023
• Jahr: 9 October 2023
• Umfang: 17 S.
• Fussnoten: Veröffentlicht: 9. Oktober 2023 ; Gesehen am 15.12.2023
• Titel Quelle: Enthalten in: Journal of Clinical Medicine
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2023
• Band/Heft Quelle: 12(2023), 19, Artikel-ID 6424, Seite 1-17
• ISSN Quelle: 2077-0383
• DOI: doi:10.3390/jcm12196424
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: biopsy needle size
• Sach-SW: bleeding
• Sach-SW: clotting disorder
• Sach-SW: hypertension
• Sach-SW: indication
• Sach-SW: laparoscopic-assisted biopsy
• Sach-SW: real-time ultrasound
• Sach-SW: renal biopsy
• Sach-SW: spring-loaded biopsy device
• Sach-SW: transjugular renal biopsy
• K10plus-PPN: 1876193654

Abstract

Renal biopsies are the gold standard for diagnosis, staging, and prognosis of underlying parenchymal kidney disease. This article provides an overview of the current indications and highlights ways to reduce bleeding complications in order to achieve optimal diagnostic yield with minimal risk to the patient. Novel indications have emerged from the increasing use of new molecularly targeted oncologic therapies in recent years, which often induce immune-mediated renal disease. On the other hand, the detection of specific antibodies against target antigens on podocytes in the sera of patients with new-onset nephrotic syndrome has now relativized the indication for biopsy in membranous nephropathy. The use of semi-automatic spring-loaded biopsy devices and real-time ultrasound considerably declined the complication rate and is the current standard. Percutaneous renal biopsies are overall a safe procedure if contraindications are considered. A coagulation disorder needs to be excluded beforehand, and an elevated blood pressure must be reduced to the normotensive range with medications. A laparoscopic approach or a radiology interventional procedure through the internal jugular vein may be considered for obtaining a kidney tissue sample if there is an urgent indication and a bleeding tendency cannot be adequately corrected. Major bleeding after a percutaneous renal biopsy can usually be managed with selective arterial embolization of the injured renal vessel. The use of a 16-gauge needle is the most reasonable compromise between diagnostic benefit and risk of complication. In the routine diagnostic, the biopsy specimen is examined with light microscopy, immunohistochemistry, and electron microscopy. Combination with modern molecular pathology techniques will contribute to more precise insights into the development and progression of kidney disease, which will likely refine future treatments in nephrology.